Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. Findings for 5 large cohorts of young adult and middle-aged men and women

JAMA

Volumn 282, Issue 21, 1999, Pages 2012-2018

  Stamler, Jeremiah ^a   Stamler, Rose ^a   Neaton, James D ^b   Wentworth, Deborah ^b   Daviglus, Martha L ^a   Garside, Dan ^a   Dyer, Alan R ^a   Liu, Kiang ^a   Greenland, Philip ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY RISK; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 0033485508     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.21.2012     Document Type: Article

References (35)

1. Stamler J. Lectures on Preventive Cardiology. New York, NY: Grune & Stratton; 1967.
2. Inter-Society Commission for Heart Disease Resources, Atherosclerosis Study Group, and Epidemiology Study Group. Primary prevention of the atherosclerotic diseases. Circulation. 1970;42:A55-A95.
3. Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis. 1978;31:201-306.
4. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA, for the Bogalusa Heart Study. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med. 1998;338:1650-1656.
5. Stamler J, Greenland P, Neaton JD. The established major risk factors underlying epidemic coronary and cardiovascular disease. CVD Prevention. 1998;1:82-97.
6. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med. 1998; 158:2007-2014.
7. National High Blood Pressure Education Program. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157: 2413-2446.
8. Stamler J, Stamler R, Brown WV, et al. Serum cholesterol: doing the right thing. Circulation. 1993;88: 1954-1960.
9. Watts GF, Lewis B, Brunt JN, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet. 1992;339: 563-569.
10. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-1389.
11. Shepard J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333:1301-1307.
12. Sacks FM, Pfeffer MA, Move LA, et al, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
13. Downs JR, Clearfield M, Weis S, et al, for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA. 1998;279:1615-1622.
14. The Long-Term Intervention With Pravastatin in lschaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339: 1349-1357.
15. Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Rockville, Md: US Dept of Health and Human Services, Public Health Service; 1990: 628.
16. Rose G, Colwell L. Randomized controlled trial of anti-smoking advice: final (20 year) results. J Epidemiol Community Health. 1992;46:75-77.
17. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology. 1993;82:191-222.
18. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA. 1982;248: 1465-1477.
19. Stamler J, Caggiula AW, Cutler JA, et al. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr. 1997; 65(suppl):183S-402S.
20. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization; 1977.
21. World Health Organization. International Classification of Diseases, Eighth Revision (ICD-8). Geneva, Switzerland: World Health Organization; 1967.
22. National Center for Health Statistics. Vital Statistics of the United States, 1990. Vol 2. Washington, DC: Public Health Service; 1994:12.
23. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-1847.
24. Daviglus ML, Liu K, Greenland P, et al. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med. 1998;339:1112-1129.
25. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
26. Stamler J, Shekelle R. Dietary cholesterol and human coronary heart disease: the epidemiologic evidence. Arch Pathol Lab Med. 1988;112:1032-1040.
27. Wilmshurst P. Temperature and cardiovascular mortality [editorial]. BMJ. 1994;309:1029-1030.
28. Stamler J, Stamler R, Garside D, et al. Socioeconomic status, cardiovascular risk factors, and cardiovascular disease: findings on U.S. working populations. In: Stamler J, Hayerda HP, eds. Report of the Conference on Socioeconomic Status and Cardiovascular Health and Disease, November 6-7, 1995. Bethesda, Md: National Heart, Lung, and Blood Institute; 1996:109-118.
29. Ernst ND, Sempos CT, Briefel RR, Clark MB. Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination Surveys. Am J Clin Nutr. 1997; 66(suppl 4):965S-972S.
30. Stamler J. The INTERSALT Study: background, methods, findings, and Implications. Am J Clin Nutr. 1997;65(suppl):626S-642S.
31. National Research Council Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press; 1989.
32. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med. 1993;153:186-208.
33. Stamler J. Setting the TONE for ending the hypertension epidemic [editorial]. JAMA. 1998;279:878-879.
34. Appel LJ, Moore TJ, Obarzanek E, et al, for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
35. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1960-1991. Hypertension. 1995; 303:305-313.